{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T11:27:10Z","timestamp":1793791630443,"version":"4.6.1"},"reference-count":186,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T00:00:00Z","timestamp":1709078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271478"],"award-info":[{"award-number":["82271478"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371411"],"award-info":[{"award-number":["82371411"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.biopha.2024.116371","type":"journal-article","created":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T00:02:55Z","timestamp":1709337775000},"page":"116371","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Therapeutic potential of natural killer cells in neuroimmunological diseases"],"prefix":"10.1016","volume":"173","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5094-2747","authenticated-orcid":false,"given":"Qing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengge","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bitao","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.biopha.2024.116371_bib1","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1002\/eji.202049028","article-title":"Human NK cells, their receptors and function","volume":"51","author":"Quatrini","year":"2021","journal-title":"Eur. J. Immunol."},{"issue":"9","key":"10.1016\/j.biopha.2024.116371_bib2","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.4049\/jimmunol.1701500","article-title":"Single degranulations in NK cells can mediate target cell killing","volume":"200","author":"Gwalani","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2024.116371_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2023.108212","article-title":"Non-viral engineering of NK cells","author":"Hinnekens","year":"2023","journal-title":"Biotechnol. Adv."},{"issue":"5","key":"10.1016\/j.biopha.2024.116371_bib4","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41423-019-0206-4","article-title":"Human NK cells: surface receptors, inhibitory checkpoints, and translational applications","volume":"16","author":"Sivori","year":"2019","journal-title":"Cell Mol. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116371_bib5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1084\/jem.20181076","article-title":"Inducible down-regulation of MHC class I results in natural killer cell tolerance","volume":"216","author":"Bern","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biopha.2024.116371_bib6","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.3389\/fimmu.2018.02796","article-title":"Memory-Like NK Cells: remembering a previous activation by cytokines and NK cell receptors","volume":"9","author":"Pahl","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2024.116371_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115718","article-title":"Cytokine-Induced Memory-Like NK Cells: Emerging strategy for AML immunotherapy","volume":"168","author":"Bakhtiyaridovvombaygi","year":"2023","journal-title":"Biomed. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2024.116371_bib8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/JLB.3MR0820-685R","article-title":"Regulatory functions of NK cells during infections and cancer","volume":"109","author":"Zwirner","year":"2021","journal-title":"J. Leukoc. Biol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116371_bib9","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3390\/toxins5020363","article-title":"On the role of natural killer cells in neurodegenerative diseases","volume":"5","author":"Maghazachi","year":"2013","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.biopha.2024.116371_bib10","article-title":"NK Cells in Autoimmune Diseases: Protective or Pathogenic?","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2024.116371_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102956","article-title":"Involvement of trained immunity during autoimmune responses","volume":"137","author":"Mora","year":"2023","journal-title":"J. Autoimmun."},{"issue":"2","key":"10.1016\/j.biopha.2024.116371_bib12","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.autrev.2017.11.018","article-title":"NK cells in autoimmune diseases: linking innate and adaptive immune responses","volume":"17","author":"Gianchecchi","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.biopha.2024.116371_bib13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cytogfr.2018.08.001","article-title":"Natural killer cells in inflammation and autoimmunity","volume":"42","author":"Zitti","year":"2018","journal-title":"Cytokine Growth Factor Rev."},{"issue":"7","key":"10.1016\/j.biopha.2024.116371_bib14","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41582-021-00496-7","article-title":"Fundamental mechanistic insights from rare but paradigmatic neuroimmunological diseases","volume":"17","author":"Wiendl","year":"2021","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116371_bib15","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s41232-021-00184-5","article-title":"Interleukin-6: evolving role in the management of neuropathic pain in neuroimmunological disorders","volume":"41","author":"Serizawa","year":"2021","journal-title":"Inflamm. Regen."},{"issue":"5","key":"10.1016\/j.biopha.2024.116371_bib16","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41582-022-00646-5","article-title":"Vaccination and immunotherapies in neuroimmunological diseases","volume":"18","author":"Winkelmann","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.biopha.2024.116371_bib17","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.73849","article-title":"Single-cell profiling reveals periventricular CD56(bright) NK cell accumulation in multiple sclerosis","volume":"11","author":"Rodriguez-Lorenzo","year":"2022","journal-title":"Elife"},{"issue":"5","key":"10.1016\/j.biopha.2024.116371_bib18","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000852","article-title":"High-throughput investigation of molecular and cellular biomarkers in NMOSD","volume":"7","author":"Yandamuri","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"9-10","key":"10.1016\/j.biopha.2024.116371_bib19","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1177\/0963689719852354","article-title":"TGF-beta in mice ameliorates experimental autoimmune encephalomyelitis in regulating NK cell activity","volume":"28","author":"Xu","year":"2019","journal-title":"Cell Transpl."},{"issue":"2","key":"10.1016\/j.biopha.2024.116371_bib20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0022-510X(98)00065-3","article-title":"Natural killer cells in patients with Guillain-Barre syndrome","volume":"157","author":"Yoshii","year":"1998","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.biopha.2024.116371_bib21","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3389\/fimmu.2019.00515","article-title":"Immune cell profiling of the cerebrospinal fluid provides pathogenetic insights into inflammatory neuropathies","volume":"10","author":"Heming","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2024.116371_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107880","article-title":"Natural killer cells promote the differentiation of follicular helper T cells instead of inducing apoptosis in myasthenia gravis","volume":"98","author":"Liu","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"10","key":"10.1016\/j.biopha.2024.116371_bib23","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.3390\/cells10102551","article-title":"NK cell patterns in idiopathic inflammatory myopathies with pulmonary affection","volume":"10","author":"Pawlitzki","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2024.116371_bib24","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/6316581","article-title":"Improved antitumor effect of NK cells activated by neutrophils in a bone marrow transplant model","volume":"2023","author":"Nakato","year":"2023","journal-title":"Mediat. Inflamm."},{"issue":"2","key":"10.1016\/j.biopha.2024.116371_bib25","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jaci.2022.09.022","article-title":"Human natural killer cells: form, function, and development","volume":"151","author":"Mace","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2024.116371_bib26","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.3390\/cancers12061591","article-title":"Transcriptional regulation of natural killer cell development and functions","volume":"12","author":"Wang","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.biopha.2024.116371_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.02.029","article-title":"SnapShot: Natural Killer Cells","volume":"180","author":"Crinier","year":"2020","journal-title":"Cell"},{"issue":"15","key":"10.1016\/j.biopha.2024.116371_bib28","doi-asserted-by":"crossref","first-page":"5779","DOI":"10.3390\/molecules28155779","article-title":"In Vivo Zymosan Treatment Induces IL15-Secreting Macrophages and KLRG1-Expressing NK Cells in Mice","volume":"28","author":"Park","year":"2023","journal-title":"Molecules"},{"issue":"20","key":"10.1016\/j.biopha.2024.116371_bib29","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1182\/blood-2011-04-348912","article-title":"Identification of the earliest natural killer cell-committed progenitor in murine bone marrow","volume":"118","author":"Fathman","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2024.116371_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2021.101501","article-title":"Cytokines and signaling pathways involved in differentiation potential of hematopoietic stem cells towards natural killer cells","volume":"70","author":"Montazersaheb","year":"2021","journal-title":"Tissue Cell"},{"issue":"19","key":"10.1016\/j.biopha.2024.116371_bib31","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1182\/blood-2010-04-282301","article-title":"CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset","volume":"116","author":"Lopez-Verges","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.biopha.2024.116371_bib32","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1038\/s41467-019-11947-7","article-title":"Heterogeneity of human bone marrow and blood natural killer cells defined by single-cell transcriptome","volume":"10","author":"Yang","year":"2019","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2024.116371_bib33","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41392-022-01058-z","article-title":"Natural killer cell homing and trafficking in tissues and tumors: from biology to application","volume":"7","author":"Ran","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"issue":"653","key":"10.1016\/j.biopha.2024.116371_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abm9043","article-title":"NK cells with tissue-resident traits shape response to immunotherapy by inducing adaptive antitumor immunity","volume":"14","author":"Kirchhammer","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.biopha.2024.116371_bib35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.smim.2017.07.006","article-title":"Diversity of tissue-resident NK cells","volume":"31","author":"Peng","year":"2017","journal-title":"Semin Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116371_bib36","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/imr.12705","article-title":"JAK\/STAT signaling in regulation of innate lymphoid cells: The gods before the guardians","volume":"286","author":"Stabile","year":"2018","journal-title":"Immunol. Rev."},{"issue":"5","key":"10.1016\/j.biopha.2024.116371_bib37","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/s41590-021-00909-1","article-title":"Deconvoluting global cytokine signaling networks in natural killer cells","volume":"22","author":"Wiedemann","year":"2021","journal-title":"Nat. Immunol."},{"issue":"8","key":"10.1016\/j.biopha.2024.116371_bib38","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/cyto.a.22302","article-title":"Human NK cell receptors\/markers: a tool to analyze NK cell development, subsets and function","volume":"83","author":"Montaldo","year":"2013","journal-title":"Cytom. A"},{"issue":"9","key":"10.1016\/j.biopha.2024.116371_bib39","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1007\/s00262-022-03161-0","article-title":"Comparison of characteristics and tumor targeting properties of extracellular vesicles derived from primary NK cells or NK-cell lines stimulated with IL-15 or IL-12\/15\/18","volume":"71","author":"Aarsund","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.biopha.2024.116371_bib40","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cyto.2019.02.001","article-title":"The role of cytokines in the regulation of NK cells in the tumor environment","volume":"117","author":"Konjevic","year":"2019","journal-title":"Cytokine"},{"issue":"6","key":"10.1016\/j.biopha.2024.116371_bib41","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s41417-021-00352-2","article-title":"Cytokine-enhanced cytolytic activity of exosomes from NK Cells","volume":"29","author":"Enomoto","year":"2022","journal-title":"Cancer Gene Ther."},{"issue":"11","key":"10.1016\/j.biopha.2024.116371_bib42","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1182\/blood-2016-02-698027","article-title":"IL-15 activates mTOR and primes stress-activated gene expression leading to prolonged antitumor capacity of NK cells","volume":"128","author":"Mao","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.biopha.2024.116371_bib43","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/s41467-017-01477-5","article-title":"Critical functions for STAT5 tetramers in the maturation and survival of natural killer cells","volume":"8","author":"Lin","year":"2017","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.biopha.2024.116371_bib44","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3109\/10799893.2012.700716","article-title":"Genetic regulation on ex vivo differentiated natural killer cells from human umbilical cord blood CD34+ cells","volume":"32","author":"Pinho","year":"2012","journal-title":"J. Recept Signal Transduct. Res."},{"issue":"2","key":"10.1016\/j.biopha.2024.116371_bib45","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1084\/jem.20141703","article-title":"PDK1 orchestrates early NK cell development through induction of E4BP4 expression and maintenance of IL-15 responsiveness","volume":"212","author":"Yang","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biopha.2024.116371_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.791220","article-title":"Tcf1 sustains the expression of multiple regulators in promoting early natural killer cell development","volume":"12","author":"Liu","year":"2021","journal-title":"Front Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2024.116371_bib47","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/eji.201747299","article-title":"T-bet and Eomes govern differentiation and function of mouse and human NK cells and ILC1","volume":"48","author":"Zhang","year":"2018","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.biopha.2024.116371_bib48","first-page":"1","article-title":"Transcriptional control of NK cells","volume":"395","author":"Sun","year":"2016","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116371_bib49","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jcyt.2014.08.003","article-title":"Differential activation of cord blood and peripheral blood natural killer cells by cytokines","volume":"17","author":"Alnabhan","year":"2015","journal-title":"Cytotherapy"},{"issue":"2","key":"10.1016\/j.biopha.2024.116371_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.188860","article-title":"The mechanobiology of NK cells- 'Forcing NK to Sense' target cells","volume":"1878","author":"Wong","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"7","key":"10.1016\/j.biopha.2024.116371_bib51","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.4049\/jimmunol.1502570","article-title":"Human CD56bright NK cells: an update","volume":"196","author":"Michel","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2024.116371_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115004","article-title":"Driving natural killer cell-based cancer immunotherapy for cancer treatment: an arduous journey to promising ground","volume":"165","author":"Jiang","year":"2023","journal-title":"Biomed. Pharm."},{"issue":"8","key":"10.1016\/j.biopha.2024.116371_bib53","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1002\/eji.202048953","article-title":"Natural killer cell engagers in cancer immunotherapy: next generation of immuno-oncology treatments","volume":"51","author":"Demaria","year":"2021","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116371_bib54","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12943-020-01238-x","article-title":"Natural killer cells in cancer biology and therapy","volume":"19","author":"Wu","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2024.116371_bib55","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2147\/JIR.S342399","article-title":"Dietary fish oil increases the number of CD11b+ CD27\u2212 NK cells at the inflammatory site and enhances key hallmarks of resolution of murine antigen-induced peritonitis","author":"Jensen","year":"2022","journal-title":"J. Inflamm. Res"},{"key":"10.1016\/j.biopha.2024.116371_bib56","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1600-065X.2006.00454.x","article-title":"Functional subsets of mouse natural killer cells","volume":"214","author":"Hayakawa","year":"2006","journal-title":"Immunol. Rev."},{"issue":"5","key":"10.1016\/j.biopha.2024.116371_bib57","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/eji.200940056","article-title":"Murine CXCR3+CD27bright NK cells resemble the human CD56bright NK-cell population","volume":"40","author":"Marquardt","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.biopha.2024.116371_bib58","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cellimm.2017.12.008","article-title":"Intrahepatic recruitment of cytotoxic NK cells contributes to autoimmune hepatitis progression","volume":"327","author":"Xiao","year":"2018","journal-title":"Cell Immunol."},{"key":"10.1016\/j.biopha.2024.116371_bib59","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.imlet.2016.05.007","article-title":"Human NK cells: from surface receptors to clinical applications","volume":"178","author":"Moretta","year":"2016","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.biopha.2024.116371_bib60","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.19.1.197","article-title":"Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis","volume":"19","author":"Moretta","year":"2001","journal-title":"Annu Rev. Immunol."},{"issue":"8","key":"10.1016\/j.biopha.2024.116371_bib61","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1093\/molbev\/msi162","article-title":"NKp30 (NCR3) is a pseudogene in 12 inbred and wild mouse strains, but an expressed gene in Mus caroli","volume":"22","author":"Hollyoake","year":"2005","journal-title":"Mol. Biol. Evol."},{"issue":"12","key":"10.1016\/j.biopha.2024.116371_bib62","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1007\/s00262-017-2104-x","article-title":"Splice variants of human natural cytotoxicity receptors: novel innate immune checkpoints","volume":"67","author":"Shemesh","year":"2018","journal-title":"Cancer Immunol. Immunother."},{"issue":"8","key":"10.1016\/j.biopha.2024.116371_bib63","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.it.2011.06.001","article-title":"Unifying concepts of MHC-dependent natural killer cell education","volume":"32","author":"Elliott","year":"2011","journal-title":"Trends Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116371_bib64","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.it.2017.12.001","article-title":"Natural killer cell education and the response to infection and cancer therapy: stay tuned","volume":"39","author":"Boudreau","year":"2018","journal-title":"Trends Immunol."},{"issue":"21","key":"10.1016\/j.biopha.2024.116371_bib65","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.1158\/1078-0432.CCR-19-2095","article-title":"The NKG2A\u2013HLA-E axis as a novel checkpoint in the tumor microenvironment","volume":"26","author":"Borst","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.biopha.2024.116371_bib66","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/cmi.2016.26","article-title":"NK cell education via nonclassical MHC and non-MHC ligands","volume":"14","author":"He","year":"2017","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.biopha.2024.116371_bib67","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-020711-075005","article-title":"Controlling natural killer cell responses: integration of signals for activation and inhibition","volume":"31","author":"Long","year":"2013","journal-title":"Annu. Rev. Immunol."},{"issue":"22","key":"10.1016\/j.biopha.2024.116371_bib68","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163620","article-title":"Blockade of the immunosuppressive KIR2DL5\/PVR pathway elicits potent human NK cell\u2013mediated antitumor immunity","volume":"132","author":"Ren","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2024.116371_bib69","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.3389\/fimmu.2019.01302","article-title":"Single-cell high-throughput technologies in cerebrospinal fluid research and diagnostics","volume":"10","author":"Lanz","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2024.116371_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102975","article-title":"CAR-NK cells: A promising cellular immunotherapy for cancer","volume":"59","author":"Xie","year":"2020","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.biopha.2024.116371_bib71","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12974-019-1437-0","article-title":"Laquinimod, a prototypic quinoline-3-carboxamide and aryl hydrocarbon receptor agonist, utilizes a CD155-mediated natural killer\/dendritic cell interaction to suppress CNS autoimmunity","volume":"16","author":"Ott","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.biopha.2024.116371_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.869447","article-title":"Natural killer cells in multiple sclerosis: entering the stage","volume":"13","author":"Belien","year":"2022","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.biopha.2024.116371_bib73","doi-asserted-by":"crossref","first-page":"5355","DOI":"10.4049\/jimmunol.1203401","article-title":"NK cells in central nervous system disorders","volume":"190","author":"Poli","year":"2013","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.biopha.2024.116371_bib74","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/ni.3816","article-title":"T-bet-dependent NKp46(+) innate lymphoid cells regulate the onset of T(H)17-induced neuroinflammation","volume":"18","author":"Kwong","year":"2017","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116371_bib75","doi-asserted-by":"crossref","DOI":"10.1002\/bies.202100281","article-title":"Eomes and T-bet, a dynamic duo regulating NK cell differentiation","volume":"44","author":"Zhang","year":"2022","journal-title":"Bioessays"},{"issue":"18","key":"10.1016\/j.biopha.2024.116371_bib76","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.1182\/blood-2011-06-362574","article-title":"Sequential desensitization of CXCR4 and S1P5 controls natural killer cell trafficking","volume":"118","author":"Mayol","year":"2011","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.biopha.2024.116371_bib77","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1002\/eji.201546194","article-title":"CX3CR1-dependent recruitment of mature NK cells into the central nervous system contributes to control autoimmune neuroinflammation","volume":"46","author":"Hertwig","year":"2016","journal-title":"Eur. J. Immunol."},{"issue":"1-2","key":"10.1016\/j.biopha.2024.116371_bib78","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jneuroim.2007.07.024","article-title":"CCL19 is constitutively expressed in the CNS, up-regulated in neuroinflammation, active and also inactive multiple sclerosis lesions","volume":"190","author":"Krumbholz","year":"2007","journal-title":"J. Neuroimmunol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116371_bib79","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/gerona\/glac173","article-title":"Natural Killer Cells Disrupt Nerve Fibers by Granzyme H in Atheriosclerotic Cerebral Small Vessel Disease","volume":"78","author":"Yu","year":"2023","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2024.116371_bib80","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.molmed.2021.12.008","article-title":"NK cells in the brain: implications for brain tumor development and therapy","volume":"28","author":"Balatsoukas","year":"2022","journal-title":"Trends Mol. Med."},{"issue":"4","key":"10.1016\/j.biopha.2024.116371_bib81","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.immuni.2018.03.012","article-title":"Interleukin-15 complex treatment protects mice from cerebral malaria by inducing interleukin-10-producing natural killer cells","volume":"48","author":"Burrack","year":"2018","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.biopha.2024.116371_bib82","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1038\/s12276-020-00505-7","article-title":"The role of natural killer cells in Parkinson\u2019s disease","volume":"52","author":"Earls","year":"2020","journal-title":"Exp. Mol. Med."},{"issue":"4","key":"10.1016\/j.biopha.2024.116371_bib83","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1177\/1352458518800776","article-title":"Enhancing natural killer cells is beneficial in multiple sclerosis\u2013Yes","volume":"25","author":"Laroni","year":"2019","journal-title":"Mult. Scler."},{"key":"10.1016\/j.biopha.2024.116371_bib84","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fcimb.2020.00036","article-title":"NK cells regulate CD8(+) T cell mediated autoimmunity","volume":"10","author":"Lang","year":"2020","journal-title":"Front. Cell Infect. Microbiol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116371_bib85","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-2567.2009.03225.x","article-title":"Inflammation in neurodegenerative diseases","volume":"129","author":"Amor","year":"2010","journal-title":"Immunology"},{"issue":"6","key":"10.1016\/j.biopha.2024.116371_bib86","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1002\/eji.201444960","article-title":"GM-CSF promotes migration of human monocytes across the blood brain barrier","volume":"45","author":"Vogel","year":"2015","journal-title":"Eur. J. Immunol."},{"issue":"7","key":"10.1016\/j.biopha.2024.116371_bib87","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1007\/s12264-021-00654-3","article-title":"Activated natural killer cells hit neurogenesis in the aging brain","volume":"37","author":"Cuapio","year":"2021","journal-title":"Neurosci. Bull."},{"issue":"2","key":"10.1016\/j.biopha.2024.116371_bib88","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.trsl.2014.08.005","article-title":"The meninges: new therapeutic targets for multiple sclerosis","volume":"165","author":"Russi","year":"2015","journal-title":"Transl. Res."},{"issue":"10","key":"10.1016\/j.biopha.2024.116371_bib89","first-page":"CD012936","article-title":"Palliative care interventions for people with multiple sclerosis","volume":"10","author":"Latorraca","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"issue":"11","key":"10.1016\/j.biopha.2024.116371_bib90","doi-asserted-by":"crossref","first-page":"5728","DOI":"10.3390\/cimb44110388","article-title":"Oral administration of myelin oligodendrocyte glycoprotein attenuates experimental autoimmune encephalomyelitis through induction of Th2\/treg cells and suppression of Th1\/Th17 immune responses","volume":"44","author":"Haghmorad","year":"2022","journal-title":"Curr. Issues Mol. Biol."},{"issue":"7846","key":"10.1016\/j.biopha.2024.116371_bib91","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41586-020-03116-4","article-title":"Gut-licensed IFN\u03b3+ NK cells drive LAMP1+ TRAIL+ anti-inflammatory astrocytes","volume":"590","author":"Sanmarco","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2024.116371_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102957","article-title":"The immunomodulatory roles of the gut microbiome in autoimmune diseases of the central nervous system: multiple sclerosis as a model","volume":"137","author":"Hoffman","year":"2023","journal-title":"J. Autoimmun."},{"issue":"2","key":"10.1016\/j.biopha.2024.116371_bib93","doi-asserted-by":"crossref","first-page":"781","DOI":"10.4049\/jimmunol.1100789","article-title":"Unexpected role for granzyme K in CD56bright NK cell-mediated immunoregulation of multiple sclerosis","volume":"187","author":"Jiang","year":"2011","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.biopha.2024.116371_bib94","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.4049\/jimmunol.180.7.4495","article-title":"In vivo regulation of experimental autoimmune encephalomyelitis by NK cells: alteration of primary adaptive responses","volume":"180","author":"Winkler-Pickett","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2024.116371_bib95","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.909275","article-title":"Innate Lymphoid cells - neglected players in multiple sclerosis","volume":"13","author":"Sadeghi Hassanabadi","year":"2022","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116371_bib96","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3390\/biomedicines10020335","article-title":"Regulatory cells in multiple sclerosis: from blood to brain","volume":"10","author":"Calahorra","year":"2022","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.biopha.2024.116371_bib97","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/s41467-019-14118-w","article-title":"Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis","volume":"11","author":"Schafflick","year":"2020","journal-title":"Nat. Commun."},{"issue":"37","key":"10.1016\/j.biopha.2024.116371_bib98","doi-asserted-by":"crossref","first-page":"22932","DOI":"10.1073\/pnas.2008523117","article-title":"A pathogenic and clonally expanded B cell transcriptome in active multiple sclerosis","volume":"117","author":"Ramesh","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.biopha.2024.116371_bib99","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/intimm\/dxq463","article-title":"Impaired IFN-\u03b3 production and proliferation of NK cells in multiple sclerosis","volume":"23","author":"L\u00fcnemann","year":"2011","journal-title":"Int Immunol."},{"issue":"1-2","key":"10.1016\/j.biopha.2024.116371_bib100","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jneuroim.2013.10.004","article-title":"Circulating CD56dim NK cells expressing perforin are increased in progressive multiple sclerosis","volume":"265","author":"Plantone","year":"2013","journal-title":"J. Neuroimmunol."},{"issue":"21","key":"10.1016\/j.biopha.2024.116371_bib101","doi-asserted-by":"crossref","first-page":"E2973","DOI":"10.1073\/pnas.1524924113","article-title":"Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation","volume":"113","author":"Gross","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"Pt 7","key":"10.1016\/j.biopha.2024.116371_bib102","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1093\/brain\/awn118","article-title":"Cytometric profiling in multiple sclerosis uncovers patient population structure and a reduction of CD8low cells","volume":"131","author":"De Jager","year":"2008","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.biopha.2024.116371_bib103","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/ana.21695","article-title":"Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis","volume":"65","author":"Lorentzen","year":"2009","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116371_bib104","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.clim.2011.09.006","article-title":"Natural killer cell phenotype and clinical response to interferon-beta therapy in multiple sclerosis","volume":"141","author":"Martinez-Rodriguez","year":"2011","journal-title":"Clin. Immunol."},{"issue":"15","key":"10.1016\/j.biopha.2024.116371_bib105","doi-asserted-by":"crossref","first-page":"5941","DOI":"10.1073\/pnas.0601335103","article-title":"Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis","volume":"103","author":"Bielekova","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.biopha.2024.116371_bib106","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.4049\/jimmunol.0902238","article-title":"An IL-2 paradox: blocking CD25 on T cells induces IL-2-driven activation of CD56(bright) NK cells","volume":"185","author":"Martin","year":"2010","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.biopha.2024.116371_bib107","doi-asserted-by":"crossref","first-page":"271","DOI":"10.33588\/rn.6608.2018083","article-title":"Daclizumab in multiple sclerosis","volume":"66","author":"Perez-Miralles","year":"2018","journal-title":"Rev. Neurol."},{"issue":"6","key":"10.1016\/j.biopha.2024.116371_bib108","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000289","article-title":"Alemtuzumab treatment alters circulating innate immune cells in multiple sclerosis","volume":"3","author":"Gross","year":"2016","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.biopha.2024.116371_bib109","doi-asserted-by":"crossref","first-page":"570","DOI":"10.4049\/jimmunol.1003823","article-title":"Reduction of the peripheral blood CD56(bright) NK lymphocyte subset in FTY720-treated multiple sclerosis patients","volume":"187","author":"Johnson","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2024.116371_bib110","doi-asserted-by":"crossref","first-page":"834","DOI":"10.3389\/fimmu.2018.00834","article-title":"Natural killer cells regulate Th17 cells after autologous hematopoietic stem cell transplantation for relapsing remitting multiple sclerosis","volume":"9","author":"Darlington","year":"2018","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.biopha.2024.116371_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103170","article-title":"The genealogy, methodology, similarities and differences of immune reconstitution therapies for multiple sclerosis and neuromyelitis optica","volume":"21","author":"Brod","year":"2022","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.biopha.2024.116371_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.conb.2022.102618","article-title":"Immunobiology of neuromyelitis optica spectrum disorders","volume":"76","author":"Mora Cuervo","year":"2022","journal-title":"Curr. Opin. Neurobiol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116371_bib113","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s40478-019-0766-7","article-title":"Complement-independent bystander injury in AQP4-IgG seropositive neuromyelitis optica produced by antibody-dependent cellular cytotoxicity","volume":"7","author":"Duan","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"issue":"6","key":"10.1016\/j.biopha.2024.116371_bib114","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00401-012-0986-4","article-title":"Neuromyelitis optica IgG and natural killer cells produce NMO lesions in mice without myelin loss","volume":"123","author":"Ratelade","year":"2012","journal-title":"Acta Neuropathol."},{"issue":"15","key":"10.1016\/j.biopha.2024.116371_bib115","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1158\/0008-5472.CAN-10-4222","article-title":"Antibody-dependent cell cytotoxicity synapses form in mice during tumor-specific antibody immunotherapy","volume":"71","author":"Hubert","year":"2011","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.biopha.2024.116371_bib116","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3390\/vaccines9060660","article-title":"Development of a macrophage-based ADCC assay","volume":"9","author":"Uccellini","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"2","key":"10.1016\/j.biopha.2024.116371_bib117","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000445215","article-title":"A Player and Coordinator: The Versatile Roles of Eosinophils in the Immune System","volume":"43","author":"Long","year":"2016","journal-title":"Transfus. Med.\u00a0Hemother."},{"issue":"4","key":"10.1016\/j.biopha.2024.116371_bib118","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1177\/147323001204000427","article-title":"Blood-brain barrier disruption is more severe in neuromyelitis optica than in multiple sclerosis and correlates with clinical disability","volume":"40","author":"Tomizawa","year":"2012","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.biopha.2024.116371_bib119","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jocn.2019.11.022","article-title":"The differential expression of natural killer cells in NMOSD and MS","volume":"71","author":"Ding","year":"2020","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.biopha.2024.116371_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104892","article-title":"Modelling MOG antibody-associated disorder and neuromyelitis optica spectrum disorder in animal models: spinal cord manifestations","volume":"78","author":"Remlinger","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"5","key":"10.1016\/j.biopha.2024.116371_bib121","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200134","article-title":"Immune repertoire profiling reveals its clinical application potential and triggers for neuromyelitis optica spectrum disorders","volume":"10","author":"Miao","year":"2023","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.biopha.2024.116371_bib122","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12974-022-02661-1","article-title":"Upregulated complement receptors correlate with Fc gamma receptor 3A-positive natural killer and natural killer-T cells in neuromyelitis optica spectrum disorder","volume":"19","author":"Nishiyama","year":"2022","journal-title":"J. Neuroinflamm."},{"issue":"10","key":"10.1016\/j.biopha.2024.116371_bib123","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/acn3.51865","article-title":"Clinical scales in autoimmune encephalitis-a retrospective monocentric cohort study","volume":"10","author":"Macher","year":"2023","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.biopha.2024.116371_bib124","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.clim.2018.12.007","article-title":"A large screen for paraneoplastic neurological autoantibodies; diagnosis and predictive values","volume":"199","author":"Seluk","year":"2019","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.biopha.2024.116371_bib125","article-title":"Activation and clonal expansion of CD8+ T cells in patients with anti-NMDAR encephalitis revealed by single-cell RNA sequencing analysis","author":"Li","year":"2023","journal-title":"medRxiv"},{"key":"10.1016\/j.biopha.2024.116371_bib126","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1075675","article-title":"Single-cell transcriptomics reveals cell type-specific immune regulation associated with anti-NMDA receptor encephalitis in humans","volume":"13","author":"Jiang","year":"2022","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2024.116371_bib127","article-title":"Encephalitis associated with hemophagocytic lymphohistiocytosis secondary to immune checkpoint inhibitors: an unfamiliar spin-off","volume":"13","author":"Ghous","year":"2021","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.biopha.2024.116371_bib128","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1177\/15357597211030175","article-title":"Hit by a smooth CD8: T-cell attack on hippocampal neurons triggers limbic encephalitis and epilepsy","volume":"21","author":"Alvarado","year":"2021","journal-title":"Epilepsy Curr."},{"key":"10.1016\/j.biopha.2024.116371_bib129","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/B978-0-444-63432-0.00007-4","article-title":"Neuropathology of autoimmune encephalitides","volume":"133","author":"Bauer","year":"2016","journal-title":"Handb. Clin. Neurol."},{"issue":"4","key":"10.1016\/j.biopha.2024.116371_bib130","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/ana.26000","article-title":"CD8+ T-lymphocyte\u2013driven limbic encephalitis results in temporal lobe epilepsy","volume":"89","author":"Pitsch","year":"2021","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116371_bib131","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.autrev.2013.10.016","article-title":"Molecular and cellular mechanisms underlying anti-neuronal antibody mediated disorders of the central nervous system","volume":"13","author":"van Coevorden-Hameete","year":"2014","journal-title":"Autoimmun. Rev."},{"issue":"9","key":"10.1016\/j.biopha.2024.116371_bib132","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s40263-022-00943-z","article-title":"Treatment options in refractory autoimmune encephalitis","volume":"36","author":"Dinoto","year":"2022","journal-title":"CNS Drugs"},{"issue":"3","key":"10.1016\/j.biopha.2024.116371_bib133","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.clim.2013.09.003","article-title":"A selective role of NKG2D in inflammatory and autoimmune diseases","volume":"149","author":"Guerra","year":"2013","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.biopha.2024.116371_bib134","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jaut.2019.04.021","article-title":"Chronic inflammatory demyelinating polyneuropathy as an autoimmune disease","volume":"102","author":"Rodriguez","year":"2019","journal-title":"J. Autoimmun."},{"issue":"23","key":"10.1016\/j.biopha.2024.116371_bib135","doi-asserted-by":"crossref","first-page":"e2386","DOI":"10.1212\/WNL.0000000000207282","article-title":"CSF findings in relation to clinical characteristics, subtype, and disease course in patients with Guillain-Barre syndrome","volume":"100","author":"Al-Hakem","year":"2023","journal-title":"Neurology"},{"issue":"1-2","key":"10.1016\/j.biopha.2024.116371_bib136","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0165-5728(00)00270-8","article-title":"Flow cytometric analysis of infiltrating cells in the peripheral nerves in experimental allergic neuritis","volume":"108","author":"Fujioka","year":"2000","journal-title":"J. Neuroimmunol."},{"issue":"1-2","key":"10.1016\/j.biopha.2024.116371_bib137","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jneuroim.2013.12.007","article-title":"Killer immunoglobulin-like receptor and their HLA ligands in Guillain\u2013Barre Syndrome","volume":"267","author":"Blum","year":"2014","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116371_bib138","doi-asserted-by":"crossref","DOI":"10.1128\/mSphereDirect.00120-18","article-title":"Zika virus infection preferentially counterbalances human peripheral monocyte and\/or NK cell activity","volume":"3","author":"Lum","year":"2018","journal-title":"mSphere"},{"issue":"2","key":"10.1016\/j.biopha.2024.116371_bib139","article-title":"Current status of zika virus vaccines: successes and challenges","volume":"8","author":"Pattnaik","year":"2020","journal-title":"Vaccines (Basel)"},{"issue":"12","key":"10.1016\/j.biopha.2024.116371_bib140","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102681","article-title":"Guillain Barre syndrome and COVID-19: Possible role of the cytokine storm","volume":"19","author":"Hussain","year":"2020","journal-title":"Autoimmun. Rev."},{"issue":"4","key":"10.1016\/j.biopha.2024.116371_bib141","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1034\/j.1600-0404.2003.00127.x","article-title":"Different clinical, electrophysiological and immunological features of CIDP associated with paraproteinaemia","volume":"108","author":"Cocito","year":"2003","journal-title":"Acta Neurol. Scand."},{"issue":"8","key":"10.1016\/j.biopha.2024.116371_bib142","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3109\/08916930903140907","article-title":"Circulating subsets and CD4(+)CD25(+) regulatory T cell function in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"42","author":"Sanvito","year":"2009","journal-title":"Autoimmunity"},{"issue":"1-2","key":"10.1016\/j.biopha.2024.116371_bib143","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jns.2013.05.015","article-title":"NK cells and their receptors in naive and rituximab-treated patients with anti-MAG polyneuropathy","volume":"331","author":"Benedetti","year":"2013","journal-title":"J. Neurol. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2024.116371_bib144","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000884","article-title":"NK cell markers predict the efficacy of IV immunoglobulins in CIDP","volume":"7","author":"Mausberg","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"6","key":"10.1016\/j.biopha.2024.116371_bib145","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1468-1331.2010.03333.x","article-title":"The effect of IgG levels on the number of natural killer cells and their Fc receptors in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"18","author":"Bohn","year":"2011","journal-title":"Eur. J. Neurol."},{"issue":"5","key":"10.1016\/j.biopha.2024.116371_bib146","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/WCO.0000000000001088","article-title":"Novel pathophysiological insights in autoimmune myasthenia gravis","volume":"35","author":"Masi","year":"2022","journal-title":"Curr. Opin. Neurol."},{"issue":"5","key":"10.1016\/j.biopha.2024.116371_bib147","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1450","article-title":"Circulating CXCR5(+) natural killer cells are expanded in patients with myasthenia gravis","volume":"12","author":"Ge","year":"2023","journal-title":"Clin. Transl. Immunol."},{"issue":"11","key":"10.1016\/j.biopha.2024.116371_bib148","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1111\/j.1468-1331.2011.03424.x","article-title":"Inhibition of peripheral blood natural killer cell cytotoxicity in patients with myasthenia gravis treated with plasmapheresis","volume":"18","author":"Chien","year":"2011","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.biopha.2024.116371_bib149","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.109184","article-title":"Single-cell mapping reveals dysregulation of immune cell populations and VISTA+ monocytes in myasthenia gravis","volume":"245","author":"Fan","year":"2022","journal-title":"Clin. Immunol."},{"issue":"1-2","key":"10.1016\/j.biopha.2024.116371_bib150","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jneuroim.2005.06.015","article-title":"Altered populations of natural killer cell and natural killer T cell subclasses in myasthenia gravis","volume":"167","author":"Suzuki","year":"2005","journal-title":"J. Neuroimmunol."},{"issue":"9","key":"10.1016\/j.biopha.2024.116371_bib151","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.4049\/jimmunol.176.9.5247","article-title":"Autoreactive T cells mediate NK cell degeneration in autoimmune disease","volume":"176","author":"Liu","year":"2006","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116371_bib152","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jaci.2022.09.010","article-title":"Azathioprine therapy induces selective NK cell depletion and IFN-gamma deficiency predisposing to herpesvirus reactivation","volume":"151","author":"Ingelfinger","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.biopha.2024.116371_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2022.577930","article-title":"The effect of immunosuppression or thymectomy on the response to tetanus revaccination in myasthenia gravis","volume":"370","author":"Strijbos","year":"2022","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.biopha.2024.116371_bib154","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jneuroim.2017.05.021","article-title":"Responsiveness to low-dose rituximab in refractory generalized myasthenia gravis","volume":"311","author":"Jing","year":"2017","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116371_bib155","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1525-1594.2012.01531.x","article-title":"A decrease in the percentage of CD3+ cells is correlated with clinical improvement during plasmapheresis in patients with myasthenia gravis","volume":"37","author":"Chien","year":"2013","journal-title":"Artif. Organs"},{"key":"10.1016\/j.biopha.2024.116371_bib156","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8781740","article-title":"The effect of immunonutrition on the postoperative complications in thymoma with myasthenia gravis","volume":"2016","author":"Xin","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.biopha.2024.116371_bib157","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jneuroim.2008.04.041","article-title":"Granzyme B: evidence for a role in the origin of myasthenia gravis","volume":"201-202","author":"Casciola-Rosen","year":"2008","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116371_bib158","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s12974-021-02298-6","article-title":"Diabetes mellitus exacerbates experimental autoimmune myasthenia gravis via modulating both adaptive and innate immunity","volume":"18","author":"Zhang","year":"2021","journal-title":"J. Neuroinflamm."},{"issue":"3","key":"10.1016\/j.biopha.2024.116371_bib159","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/79792","article-title":"Natural killer cells determine the outcome of B cell-mediated autoimmunity","volume":"1","author":"Shi","year":"2000","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116371_bib160","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/s12974-019-1687-x","article-title":"CXCR5-negative natural killer cells ameliorate experimental autoimmune myasthenia gravis by suppressing follicular helper T cells","volume":"16","author":"Yang","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.biopha.2024.116371_bib161","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.neulet.2016.05.020","article-title":"Curcumin ameliorates experimental autoimmune myasthenia gravis by diverse immune cells","volume":"626","author":"Wang","year":"2016","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.biopha.2024.116371_bib162","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5414\/NP301077","article-title":"Idiopathic inflammatory myopathies overlapping with systemic diseases","volume":"37","author":"Lepreux","year":"2018","journal-title":"Clin. Neuropathol."},{"key":"10.1016\/j.biopha.2024.116371_bib163","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1016\/j.csbj.2023.03.019","article-title":"Identification of feature genes and key biological pathways in immune-mediated necrotizing myopathy: High-throughput sequencing and bioinformatics analysis","volume":"21","author":"Chen","year":"2023","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"10","key":"10.1016\/j.biopha.2024.116371_bib164","doi-asserted-by":"crossref","first-page":"4530","DOI":"10.18632\/aging.204098","article-title":"Identification of hub biomarkers and immune cell infiltration in polymyositis and dermatomyositis","volume":"14","author":"Chen","year":"2022","journal-title":"Aging (Albany NY)"},{"issue":"41","key":"10.1016\/j.biopha.2024.116371_bib165","doi-asserted-by":"crossref","first-page":"43230","DOI":"10.18632\/oncotarget.6462","article-title":"The NKG2D\u2013IL-15 signaling pathway contributes to T-cell mediated pathology in inflammatory myopathies","volume":"6","author":"Ruck","year":"2015","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.biopha.2024.116371_bib166","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1128\/CDLI.7.4.693-697.2000","article-title":"Decreased levels of CD54 (ICAM-1)-positive lymphocytes in the peripheral blood in untreated patients with active juvenile dermatomyositis","volume":"7","author":"O'Gorman","year":"2000","journal-title":"Clin. Diagn. Lab Immunol."},{"issue":"7","key":"10.1016\/j.biopha.2024.116371_bib167","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.3899\/jrheum.121031","article-title":"Longitudinal peripheral blood lymphocyte subsets correlate with decreased disease activity in juvenile dermatomyositis","volume":"40","author":"Ernste","year":"2013","journal-title":"J. Rheuma"},{"issue":"22","key":"10.1016\/j.biopha.2024.116371_bib168","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.123236","article-title":"Dysregulated NK cell PLCgamma2 signaling and activity in juvenile dermatomyositis","volume":"3","author":"Throm","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.biopha.2024.116371_bib169","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2023.117321","article-title":"Decrease in cell counts and alteration of phenotype characterize peripheral NK cells of patients with anti-MDA5-positive dermatomyositis","volume":"543","author":"Lin","year":"2023","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.biopha.2024.116371_bib170","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10067-003-0814-2","article-title":"Dermatomyositis associated with lymphoproliferative disorder of NK cells and occult small cell lung carcinoma","volume":"23","author":"Antonioli","year":"2004","journal-title":"Clin. Rheumatol."},{"issue":"5","key":"10.1016\/j.biopha.2024.116371_bib171","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.4049\/jimmunol.1501902","article-title":"Involvement of NK Cells and NKp30 pathway in antisynthetase syndrome","volume":"197","author":"Hervier","year":"2016","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.biopha.2024.116371_bib172","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1002\/art.22790","article-title":"Novel conformation of histidyl-transfer RNA synthetase in the lung: the target tissue in Jo-1 autoantibody-associated myositis","volume":"56","author":"Levine","year":"2007","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.biopha.2024.116371_bib173","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/jnen\/nlab136","article-title":"Optimized flow cytometry strategy for phenotyping intramuscular leukocytes: application to the evaluation of myopathological processes","volume":"81","author":"Saidj","year":"2022","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"13","key":"10.1016\/j.biopha.2024.116371_bib174","doi-asserted-by":"crossref","first-page":"e1374","DOI":"10.1212\/WNL.0000000000200013","article-title":"Immunophenotyping of Inclusion Body Myositis Blood T and NK Cells","volume":"98","author":"Goyal","year":"2022","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.biopha.2024.116371_bib175","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1250","article-title":"Natural killer cells in inflammatory autoimmune diseases","volume":"10","author":"Yang","year":"2021","journal-title":"Clin. Transl. Immunol."},{"issue":"9","key":"10.1016\/j.biopha.2024.116371_bib176","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1093\/brain\/awz207","article-title":"Highly differentiated cytotoxic T cells in inclusion body myositis","volume":"142","author":"Greenberg","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.biopha.2024.116371_bib177","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.molimm.2018.12.005","article-title":"JAK\/STAT proteins and their biological impact on NK cell development and function","volume":"115","author":"Vargas-Hernandez","year":"2019","journal-title":"Mol. Immunol."},{"issue":"10","key":"10.1016\/j.biopha.2024.116371_bib178","doi-asserted-by":"crossref","first-page":"16998","DOI":"10.1002\/jcp.28421","article-title":"Flip-flops of natural killer cells in autoimmune diseases versus cancers: Immunologic axis","volume":"234","author":"Shahrabi","year":"2019","journal-title":"J. Cell Physiol."},{"issue":"6","key":"10.1016\/j.biopha.2024.116371_bib179","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1073\/pnas.0914732107","article-title":"Analysis of the cellular mechanism underlying inhibition of EAE after treatment with anti-NKG2A F(ab')2","volume":"107","author":"Leavenworth","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.biopha.2024.116371_bib180","doi-asserted-by":"crossref","first-page":"9521","DOI":"10.3390\/ijms24119521","article-title":"NK cells in cancer: mechanisms of dysfunction and therapeutic potential","volume":"24","author":"Portale","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2024.116371_bib181","article-title":"Therapeutic targeting of follicular T cells with chimeric antigen receptor-expressing natural killer cells","volume":"1","author":"Reighard","year":"2020","journal-title":"Cell Rep. Med."},{"issue":"9","key":"10.1016\/j.biopha.2024.116371_bib182","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/s41587-022-01626-2","article-title":"Control of acute myeloid leukemia by a trifunctional NKp46-CD16a-NK cell engager targeting CD123","volume":"41","author":"Gauthier","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biopha.2024.116371_bib183","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115123","article-title":"IPSC-derived CAR-NK cells for cancer immunotherapy","volume":"165","author":"Lin","year":"2023","journal-title":"Biomed. Pharm."},{"issue":"22","key":"10.1016\/j.biopha.2024.116371_bib184","doi-asserted-by":"crossref","first-page":"16040","DOI":"10.3390\/ijms242216040","article-title":"Mesenchymal stem cells in the pathogenesis and therapy of autoimmune and autoinflammatory diseases","volume":"24","author":"Zaripova","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116371_bib185","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ijbiomac.2021.02.131","article-title":"Alginate\/gelatin encapsulation promotes NK cells differentiation potential of bone marrow resident C-kit(+) hematopoietic stem cells","volume":"177","author":"Fathi","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biopha.2024.116371_bib186","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2023.101797","article-title":"The effects of encapsulation on NK cell differentiation potency of C-kit+ hematopoietic stem cells via identifying cytokine profiles","volume":"77","author":"Farahzadi","year":"2023","journal-title":"Transpl. Immunol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224002555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224002555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T10:43:59Z","timestamp":1793789039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224002555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":186,"alternative-id":["S0753332224002555"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116371","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potential of natural killer cells in neuroimmunological diseases","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116371","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116371"}}